Related Experiment Video
Updated: Dec 15, 2025
16:56
Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
Published on: August 30, 2014
17.4K
T-UCRs with digestive and respiratory diseases
Yajun Wang1, Di Zhou1, Yuan Feng1
1School of Traditional Chinese Materia Medica, Key Laboratory of Computational Chemistry-Based Natural Antitumor Drug, Shenyang Pharmaceutical University, Shenyang 110016, China.
Bioorganic & Medicinal Chemistry Letters
|July 8, 2020
Summary
Ultraconserved RNA regions (T-UCRs) are crucial in both digestive and respiratory diseases, highlighting the gut-lung axis. This review explores T-UCRs
Area of Science:
- Histoembryology and molecular biology
Background:
- The lung, gaster, and intestines share homologous origins from gastrula endoderm.
- The gut-lung axis describes the interplay between intestinal and lung pathologies.
- Ultraconserved RNA regions (T-UCRs) are highly conserved and implicated in various diseases.
Purpose of the Study:
- To review recent findings on T-UCRs in digestive and respiratory diseases, focusing on the gut-lung axis.
- To identify T-UCRs and their targets relevant to gut-lung axis pathologies.
- To provide a foundation for future therapeutic strategies targeting T-UCRs.
Main Methods:
- Literature review of recent studies on T-UCRs in digestive and respiratory diseases.
- Analysis of T-UCRs' roles within the context of the gut-lung axis.
- Identification of T-UCRs and their potential targets.
Main Results:
- T-UCRs are increasingly recognized for their significant roles in both digestive and respiratory disease pathogenesis.
- Specific T-UCRs have been linked to conditions affecting the gut and lungs.
- The gut-lung axis provides a framework for understanding shared T-UCR involvement.
Conclusions:
- T-UCRs represent a critical link between digestive and respiratory systems.
- Understanding T-UCRs in the gut-lung axis is vital for disease diagnosis and treatment.
- T-UCRs and their targets offer promising avenues for novel drug development.
Related Concept Videos
01:31Common Respiratory Disorders
1.1K
Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.1K
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
764
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
764
01:17Chronic Bowel Disorders: Introduction
678
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
678
01:17Other Pulmonary Disorders
1.4K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.4K
01:16The Respiratory System
88.5K
The respiratory system is comprised of the organs that enable breathing. Air enters the nostrils and mouth, followed by the pharynx (throat) and larynx (voice box), which lead to the trachea (windpipe). In the thoracic cavity, the trachea splits into two bronchi that allow air to enter the lungs. The bronchi split into progressively smaller bronchioles and terminate in small groups of tiny sacs in the lungs called alveoli, where gas exchange occurs.
88.5K
01:22Chronic Obstructive Pulmonary Disease
2.0K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.0K